% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • affy_lurker affy_lurker Jun 24, 2013 10:27 PM Flag

    Question to knowledgeable longs...

    1) Is it my understanding that the Takeda-AFFY agreement was AFFY was entitled to USA revs, and Takeda entitled to global revs ex-USA?
    2) I noticed Yahoo in the last few dropped dropped the book value from $1.44 to negative 37 (or something like this) cents. Seems to me they got plenty of cash for short term with not much debt. True?
    3) Can AFFY/Takeda sue Fresenius if it turns out that Fresenius is at fault. After all, AFFY and Takeda have lost a quarter plus of revs, and their good name on the product. And if so, assuming Omontys comes back to market at some time, force the issue with Fresnius in so far as offering Omontys as an alternative to AMGN EPO.?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think you can find the information in q-10 report ending March for 1 and 2. #3 the scientist know what is going on with Omontys. It all begins with the article, "Peptide could activate the erythroproietin receptor and stimulate erythrpoiesis", first described by Wrighton et al {15} in 1996 in Science. March issue, I think. Very smart individuals that discovered this stuff.